Benzinga | Jan 29, 2021 04:55AM EST

Cantor Fitzgerald Maintains Neutral on cbdMD, Raises Price Target to $4.3

Cantor Fitzgerald analyst Pablo Zuanic maintains cbdMD (AMEX:YCBD) with a Neutral and raises the price target from $3.6 to $4.3.